姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Chen,Pei-Jun | Chairman | 20.28% | Center Laboratories, Inc. |
Chen,Jun-Hong | Director | 20.28% | Center Laboratories, Inc. |
Jason Technology Co., Ltd. | Director | 0.63% | |
ZHONG JIA INVESTMENT DEVELOPMENT CO., LTD. | Director | 0.11% | |
Gao,Guo-Bin | Independent Director | 0.00% | |
Cai,Yu-Sheng | Independent Director | 0.00% | |
Zhao,Yu-Tian | Independent Director | 0.00% | |
Yan,Guo-Long | Independent Director | 0.00% |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Operating income | 121,716 | 683,924 | 652,620 |
Operating cost | 200,213 | 925,281 | 1,027,811 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | -78,497 | -241,357 | -375,191 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | -78,497 | -241,357 | -375,191 |
Operating expenses | 49,708 | 220,180 | 226,911 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | -128,205 | -461,537 | -602,102 |
Non-operating income and expenses | -1,957 | -8,049 | -81,879 |
Net profit (loss) before tax | -130,162 | -469,586 | -683,981 |
Income tax expense (benefits) | -1,025 | -2,461 | -1,134 |
Net profit (loss) of ongoing business for the current period | -129,137 | -467,125 | -682,847 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | -129,137 | -467,125 | -682,847 |
Other comprehensive profit (loss), net | 59 | 485 | 175 |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | -129,078 | -466,640 | -682,672 |
Net profit (loss) attributable to owners of parent company | -129,137 | -467,125 | -682,847 |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | -129,078 | -466,640 | -682,672 |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | 0 | -2 | -3 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | 14,288 | -191,681 | -131,178 |
Net cash inflows (outflows) from investing activities | -108,614 | -174,931 | -443,148 |
Net cash inflow (outflow) from financing activities | 90,113 | 116,575 | -229,732 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 74 | 334 | -39 |
Increase (decrease) in cash and cash equivalents in the current period | -4,139 | -249,703 | -804,097 |
Beginning balance of cash and cash equivalents | 269,565 | 519,268 | 1,323,365 |
Ending balance of cash and cash equivalents | 265,426 | 269,565 | 519,268 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Current asset | 713,574 | 736,381 | 1,098,010 |
Non-current asset | 2,625,835 | 2,631,995 | 2,672,391 |
Total asset | 3,339,409 | 3,368,376 | 3,770,401 |
Current liability | 779,625 | 661,496 | 753,423 |
Non-current liability | 662,265 | 683,401 | 569,786 |
Total liability | 1,441,890 | 1,344,897 | 1,323,209 |
share capital | 2,071,191 | 2,070,508 | 2,057,884 |
Equity - secruity token | - | - | - |
capital reserve | 423,334 | 421,109 | 1,074,289 |
retained earning | -596,044 | -466,907 | -682,641 |
Other equity | -962 | -1,231 | -2,340 |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | 1,897,519 | 2,023,479 | 2,447,192 |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 1,897,519 | 2,023,479 | 2,447,192 |
Share capital awaiting retirement (unit: share) | 0 | 0 | 200,000 |
Issued shares of advance equity (unit: shares) | 3,000 | 14,900 | 36,000 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 9 | 9 | 11 |